Table 1 Baseline Data for the training, validation, and testing datasets
From: Death risk prediction model for patients with non-traumatic intracerebral hemorrhage
Total(n = 1274) | Train(n = 764) | Validation (n = 255) | Test(n = 255) | p | |
|---|---|---|---|---|---|
Age(years) | 69.00 (59.00, 79.00) | 69.00 (59.00,80.00) | 69.00 (58.50,77.00) | 70.00 (59.00,80.00) | 0.582 |
PO2(mmHg) | 136.00 (81.00, 136.00) | 136.00(91.00,136.00) | 136.00 (71.00,136.00) | 136.00 (72.50,136.00) | 0.002 |
Platelet(K/µL) | 215.00 (171.25, 263.75) | 215.00 (169.00,259.25) | 213.00 (171.50,275.00) | 217.00 (180.50,259.00) | 0.331 |
ALT(IU/L) | 22.00 (15.00, 33.00) | 22.00 (15.00,33.00) | 23.00 (15.00,33.00) | 20.00 (15.00,33.00) | 0.852 |
AST(IU/L) | 27.00 (19.00, 46.00) | 27.00 (19.00,45.00) | 28.00 (20.00,48.00) | 26.00 (19.00,40.50) | 0.373 |
PCO2(mmHg) | 40.00 (38.00, 41.00) | 40.00 (38.00,41.00) | 40.00 (37.50,42.00) | 40.00 (37.00,42.00) | 0.627 |
White blood cell(K/µL) | 8.60 (6.70, 11.90) | 8.50 (6.70,11.62) | 8.50 (6.80,12.90) | 9.10 (6.80,11.80) | 0.232 |
Creatinine(mg/dL) | 0.90 (0.70, 1.10) | 0.90 (0.70,1.10) | 0.80 (0.70,1.05) | 0.90 (0.70,1.20) | 0.422 |
Cholesterol(mg/dL) | 172.00 (156.00, 180.00) | 172.00 (156.00,179.00) | 172.00 (161.50,178.00) | 172.00 (153.00,186.50) | 0.918 |
LDL(mg/dL) | 95.00 (83.00, 100.00) | 95.00 (83.00,100.00) | 95.00 (84.50,99.00) | 95.00 (80.00,100.00) | 0.906 |
HDL(mg/dL) | 52.00 (45.00, 53.75) | 52.00 (46.00,54.00) | 52.00 (45.50,52.00) | 52.00 (45.00,53.50) | 0.595 |
PH(units) | 7.40 (7.39, 7.41) | 7.40 (7.39,7.42) | 7.40 (7.38,7.41) | 7.40 (7.39,7.42) | 0.419 |
Albumin(g/dL) | 3.80 (3.60, 4.20) | 3.80 (3.60,4.20) | 3.80 (3.60,4.20) | 3.80 (3.60,4.20) | 0.822 |
GCS min | 12.00 (9.00, 14.00) | 12.00 (10.00,14.00) | 11.00 (9.00,14.00) | 12.00 (9.00,14.00) | 0.052 |
GCS motor | 5.00 (5.00, 6.00) | 5.00 (5.00,6.00) | 5.00 (5.00,6.00) | 5.00 (5.00,6.00) | 0.439 |
GCS eyes | 3.00 (2.00, 3.00) | 3.00 (2.00,3.00) | 3.00 (2.00,3.00) | 3.00 (2.00,3.00) | 0.238 |
Death: | 0.996 | ||||
No | 702 (55.10%) | 421 (55.10%) | 140 (54.90%) | 141 (55.29%) | |
Yes | 572 (44.90%) | 343 (44.90%) | 115 (45.10%) | 114 (44.71%) | |
Type 2 diabetes: | 0.205 | ||||
No | 935 (73.39%) | 573 (75.00%) | 185 (72.55%) | 177 (69.41%) | |
Yes | 339 (26.61%) | 191 (25.00%) | 70 (27.45%) | 78 (30.59%) | |
Atrial fibrillation: | 0.943 | ||||
No | 1040 (81.63%) | 626 (81.94%) | 207 (81.18%) | 207 (81.18%) | |
Yes | 234 (18.37%) | 138 (18.06%) | 48 (18.82%) | 48 (18.82%) | |
Pulmonary embolism: | 0.936 | ||||
No | 1194 (93.72%) | 716 (93.72%) | 238 (93.33%) | 240 (94.12%) | |
Yes | 80 (6.28%) | 48 (6.28%) | 17 (6.67%) | 15 (5.88%) | |
Deep vein thrombosis: | 0.261 | ||||
No | 1201 (94.27%) | 725 (94.90%) | 235 (92.16%) | 241 (94.51%) | |
Yes | 73 (5.73%) | 39 (5.10%) | 20 (7.84%) | 14 (5.49%) | |
Gender: | 0.851 | ||||
Male | 651 (51.10%) | 386 (50.52%) | 131 (51.37%) | 134 (52.55%) | |
Female | 623 (48.90%) | 378 (49.48%) | 124 (48.63%) | 121 (47.45%) | |
Hypertension: | 0.224 | ||||
No | 417 (32.73%) | 257 (33.64%) | 72 (28.24%) | 88 (34.51%) | |
Yes | 857 (67.27%) | 507 (66.36%) | 183 (71.76%) | 167 (65.49%) |